Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

PEGASUS UNVEILS NEW BRAND IDENTITY AS IT CELEBRATES A YEAR AS PART OF ASHFIELD

Pegasus, an Ashfield company, part of UDG Healthcare plc, has unveiled a new brand identity signaling its successful integration with the global business, a year on from acquisition. Conceived by...

Inizio

- PMLiVE

Recordati acquires AstraZeneca blood pressure brands

Italian pharma firm obtains Seloken and Logimax

- PMLiVE

MSD probed by UK for blocking Remicade biosimilars

Pharma giant’s discount scheme for infliximab labelled ‘anti-competitive’

- PMLiVE

Biogen spin-out makes first acquisition

Bioverativ attains rare disease group True North

german flag

Germany’s pharma market set for stable growth

Annual growth of 4.9% expected over next four years

How personalising multichannel improves customer experience

You’ve started your multichannel journey, and your customer-facing staff are connecting healthcare professionals to new channels. Great! Providing content in other channels extends customer relationships. Now, with HCP access at...

Anthill Agency

- PMLiVE

Keytruda is first FDA-approved drug for molecular indication

Indicates a significant development in the shift towards personalised medicine

- PMLiVE

Otsuka refiles ‘digital’ medicine for mental illness

Soluble sensor tracks drug ingestion and shares information with HCPs

How can pharma engage with Accountable Care Systems?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, explain how pharma can add value across care pathways

Wilmington Healthcare

Your career starts here

When working in medical communications, one of the most common questions we get asked is “What is it that you actually do?” Many students and graduates are unaware of medical...

Lucid Group Communications Limited

- PMLiVE

Merck says Afferent’s chronic cough drug clears mid-stage trial

MK-7264 reduces coughs per hour by 37%

Sanofi reception

Sanofi/Regeneron’s Sarilumab cleared by FDA on second attempt

IL-6 inhibitor to treat adult RA patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links